For the Inventor, By the Inventor

Enter assignee name

Exton, PA, United States of America

Melior Pharmaceuticals I, Inc.

USPTO Granted Patents = 13

CIPO Patents = 9

EPO Patents = 3

Forward Citations = 57

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Andrew G Reaume (13 out of 20 patents)

Michael S Saporito (10 out of 17 patents)

Frank L Greenway (3 out of 15 patents)

4. Weina Cong (3 out of 3 patents)

5. Ann Coulter (3 out of 3 patents)

6. Alexander R Ochman (2 out of 2 patents)

7. Christopher K Lipinski (1 out of 1 patent)

8. Frank Greenway (0 patent)

13 patents: Sort by Forward Citations

1. 12070461 - Methods and formulations for modulating Lyn kinase activity and treating related disorders (2024-08-27),

2. 12064432 - Treatment of adipocytes (2024-08-20),

3. 12011445 - Prevention of pancreatic cell degeneration (2024-06-18),

4. 11534442 - Treatment of adipocytes (2022-12-27),

5. 11033548 - Methods and formulations for modulating Lyn kinase activity and treating related disorders (2021-06-15),

6. 10786503 - Treatment of adipocytes (2020-09-29),

7. 10251883 - Methods and formulations for modulating Lyn kinase activity and treating related disorders (2019-04-09),

8. 9763945 - Methods and formulations for modulating Lyn kinase activity and treating related disorders (2017-09-19),

9. 9216959 - Methods and formulations for treating cardiovascular disease (2015-12-22),

10. 8835448 - Methods and formulations for modulating lyn kinase activity and treating related disorders (2014-09-16),

11. 8552184 - Compounds and methods for treating disorders related to glucose metabolism (2013-10-08),

12. 8343985 - Methods for modulating Lyn kinase activity and treating related disorders (2013-01-01),

13. 7776870 - Methods for modulating Lyn kinase activity and treating related disorders (2010-08-17),

Melior Pharmaceuticals I, Inc. is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of metabolic diseases. With a strong pipeline of novel drug candidates and a dedicated team of scientists, Melior is committed to improving the lives of patients suffering from conditions such as diabetes, obesity, and metabolic syndrome. The company's cutting-edge research and strategic partnerships position them as a leader in the field of metabolic disease therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#19 in Exton, PA

#841 in Pennsylvania

#23,099 in US

#43,615 in the World

Exton, PA, United States of America

Melior Pharmaceuticals I, Inc.

Forward Citations = 57

13 inventors:

Andrew G Reaume (13 out of 20 patents)

Michael S Saporito (10 out of 17 patents)

Frank L Greenway (3 out of 15 patents)

4. Weina Cong (3 out of 3 patents)

5. Ann Coulter (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…